You limited your search to:

 Collection: Congressional Research Service Reports
Medicare: Prescription Drug Proposals
This report provides an overview of the President’s plan and the legislation introduced to date in the 106th Congress. It digital.library.unt.edu/ark:/67531/metacrs1048/
Medicare: Selected Prescription Drug Proposals
No Description digital.library.unt.edu/ark:/67531/metacrs1051/
Medicare: Side-by-Side Comparison of Selected Prescription Drug Bills
No Description digital.library.unt.edu/ark:/67531/metacrs1050/
Medicare: Beneficiary Cost-Sharing Under Prescription Drug Legislation
This report provides an analysis of how the cost-sharing and premium provisions under the Prescription Drug and Medicare Improvement Act of 2003 (S. 1) and the Medicare Prescription Drug and Modernization Act of 2003 (H bill would affect the amount that a beneficiary would pay annually for prescription drugs. digital.library.unt.edu/ark:/67531/metacrs3698/
Medicare: Beneficiary Cost-Sharing Under Proposed Prescription Drug Benefits
This report examines these proposals as well as the “Medicare Rx Drug Benefit and Discount Act of 2003,” which was introduced by Representative Charles Rangel, the ranking member of the House Ways and Means Committee. Specifically, this report provides background on how the cost-sharing and premium provisions under each bill would affect the amount that a beneficiary pays annually for prescription drugs. digital.library.unt.edu/ark:/67531/metacrs3699/
Medicare: Beneficiary Cost-Sharing Under Proposed Prescription Drug Benefits
This report provides background on how the cost-sharing and premium provisions under each bill would affect the amount that a beneficiary pays annually for prescription drugs. In addition, this report gives examples of how annual cost-sharing would differ for beneficiaries with various levels of total prescription drug spending in 2006 under the plans. digital.library.unt.edu/ark:/67531/metacrs3700/
Medicare Prescription Drug and Reform Legislation
This report describes the major features of S. 1, as ordered reported, and the measure to be considered by the House Ways and Means Committee, H.R. 2473, as ordered reported. digital.library.unt.edu/ark:/67531/metacrs3701/
Overview of the Medicare Prescription Drug and Reform Legislation
No Description digital.library.unt.edu/ark:/67531/metacrs3702/
Overview of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003
No Description digital.library.unt.edu/ark:/67531/metacrs5727/
Medicare Prescription Drug Provisions of S.1, as Passed by the Senate, and H.R. 1, as Passed by the House
This report discusses differences in the specifics of the prescription drug provisions in S. 1 and H.R. 1 and provides a side-by-side comparison of the Title I provisions of both bills. digital.library.unt.edu/ark:/67531/metacrs3704/
Medicare's Skilled Nursing Facility Benefit
No Description digital.library.unt.edu/ark:/67531/metacrs1366/
Tobacco Price Support: An Overview of the Program
No Description digital.library.unt.edu/ark:/67531/metacrs504/
Tobacco Price Support: An Overview of the Program
No Description digital.library.unt.edu/ark:/67531/metacrs3703/
Tobacco-Related Programs and Activities of the U.S. Department of Agriculture: Operation and Cost
No Description digital.library.unt.edu/ark:/67531/metacrs506/
Tobacco-Related Activities and Programs in the Federal Government: A Summary
No Description digital.library.unt.edu/ark:/67531/metacrs832/
Tobacco Advertising: The Constitutionality of Limiting its Tax Deductibility
No Description digital.library.unt.edu/ark:/67531/metacrs508/
Tobacco Marketing and Advertising Restrictions in S. 1648, 105th Congress: First Amendment Issues
No Description digital.library.unt.edu/ark:/67531/metacrs509/
Tobacco Issues: National Public Opinion
No Description digital.library.unt.edu/ark:/67531/metacrs510/
Tobacco Marketing and Advertising Restrictions in S. 1415, 105th Congress: First Amendment Issues
No Description digital.library.unt.edu/ark:/67531/metacrs512/
Tobacco Legislation in the 105th Congress: Side-by-Side Comparison of S. 1415, S. 1530, S. 1638, S. 1889, H.R. 3474, and H.R. 3868
No Description digital.library.unt.edu/ark:/67531/metacrs516/
Tobacco Control: Enforcement and Effectiveness of Federal and State Youth Access Laws
No Description digital.library.unt.edu/ark:/67531/metacrs515/
Federal R&D, Drug Discovery, and Pricing: Insights from the NIH-University-Industry Relationship
Interest in methods to provide drugs at lower cost, particularly for the elderly, has rekindled discussion over the role the federal government plays in facilitating the creation of new pharmaceuticals for the marketplace. This report explores the issue of whether or not the substantial federal investment in health-related research and development (R&D) entitles the public to commensurate consideration in prices charged for any resulting drugs. It is intended to provide the reader with an understanding of the rationale for government support of R&D and subsequent efforts to facilitate private sector commercialization of new technologies generated from such work. Concerns surrounding innovation in pharmaceuticals and biotechnology are discussed within the broader context of the federal role in facilitating technological progress. digital.library.unt.edu/ark:/67531/metacrs1092/
Summary and Comparison of the Major Agricultural Provisions of the Tobacco Settlement Policy Proposals
No Description digital.library.unt.edu/ark:/67531/metacrs560/
The Proposed Tobacco Settlement: Who Pays for the Health Costs of Smoking?
No Description digital.library.unt.edu/ark:/67531/metacrs561/
The Tobacco Settlement: An Overview
No Description digital.library.unt.edu/ark:/67531/metacrs399/
The Proposed Tobacco Settlement: Effects on Prices, Smoking Behavior, and Income Distribution
No Description digital.library.unt.edu/ark:/67531/metacrs562/
Compensating Farmers for the Tobacco Settlement
The legislative proposals designed to reduce smoking, primarily by teenagers, are likely to have negative economic consequences for tobacco growers and tobacco-dependent communities. This report discusses the possibility of some kind of compensation to farmers as part of the settlement package legislation. digital.library.unt.edu/ark:/67531/metacrs563/
The Tobacco Settlement: Issues
No Description digital.library.unt.edu/ark:/67531/metacrs565/
Tobacco Master Settlement Agreement (1998): Overview, Implementation by States, and Congressional Issues
No Description digital.library.unt.edu/ark:/67531/metacrs891/
Tobacco Advertising: Whether the FDA's Restrictions Violate Freedom of Speech
No Description digital.library.unt.edu/ark:/67531/metacrs402/
Medical Records Privacy: Questions and Answers on the HIPAA Final Rule
This report discusses the issue facing Congress on whether to continue to support the executive branch’s prosecution of medical marijuana patients and their providers, in accordance with marijuana’s status as a Schedule I drug under the Controlled Substances Act, or whether to relax federal marijuana prohibition enough to permit the medical use of botanical cannabis products by seriously ill persons, especially in states that have created medical marijuana programs under state law. digital.library.unt.edu/ark:/67531/metacrs1458/
Medical Records Privacy: Questions and Answers on the HIPAA Final Rule
This report discusses the issue facing Congress on whether to continue to support the executive branch’s prosecution of medical marijuana patients and their providers, in accordance with marijuana’s status as a Schedule I drug under the Controlled Substances Act, or whether to relax federal marijuana prohibition enough to permit the medical use of botanical cannabis products by seriously ill persons, especially in states that have created medical marijuana programs under state law. digital.library.unt.edu/ark:/67531/metacrs2251/
Medical Records Privacy: Questions and Answers on the HIPAA Final Rule
This report discusses the issue facing Congress on whether to continue to support the executive branch’s prosecution of medical marijuana patients and their providers, in accordance with marijuana’s status as a Schedule I drug under the Controlled Substances Act, or whether to relax federal marijuana prohibition enough to permit the medical use of botanical cannabis products by seriously ill persons, especially in states that have created medical marijuana programs under state law. digital.library.unt.edu/ark:/67531/metacrs3928/
Medical Records Privacy: Questions and Answers on the HIPAA Final Rule
This report discusses the issue facing Congress on whether to continue to support the executive branch’s prosecution of medical marijuana patients and their providers, in accordance with marijuana’s status as a Schedule I drug under the Controlled Substances Act, or whether to relax federal marijuana prohibition enough to permit the medical use of botanical cannabis products by seriously ill persons, especially in states that have created medical marijuana programs under state law. digital.library.unt.edu/ark:/67531/metacrs3929/
Medical Records Privacy: Questions and Answers on the HIPAA Final Rule
This report discusses the issue facing Congress on whether to continue to support the executive branch’s prosecution of medical marijuana patients and their providers, in accordance with marijuana’s status as a Schedule I drug under the Controlled Substances Act, or whether to relax federal marijuana prohibition enough to permit the medical use of botanical cannabis products by seriously ill persons, especially in states that have created medical marijuana programs under state law. digital.library.unt.edu/ark:/67531/metacrs5751/
Prescription Drug User Fee Act of 1992: Effects on Bringing New Drugs to Market
No Description digital.library.unt.edu/ark:/67531/metacrs416/
The Hatch-Waxman Act: Proposed Legislative Changes
No Description digital.library.unt.edu/ark:/67531/metacrs2324/
The Hatch-Waxman Act: Proposed Legislative Changes Affecting Pharmaceutical Patents
No Description digital.library.unt.edu/ark:/67531/metacrs2325/
The Hatch-Waxman Act: Proposed Legislative Changes Affecting Pharmaceutical Patents
No Description digital.library.unt.edu/ark:/67531/metacrs4051/
The Hatch-Waxman Act: Proposed Legislative Changes Affecting Pharmaceutical Patents
No Description digital.library.unt.edu/ark:/67531/metacrs4052/
The Hatch-Waxman Act: Proposed Legislative Changes Affecting Pharmaceutical Patents
No Description digital.library.unt.edu/ark:/67531/metacrs4053/
The Hatch-Waxman Act: Proposed Legislative Changes Affecting Pharmaceutical Patents
No Description digital.library.unt.edu/ark:/67531/metacrs4054/
The Hatch-Waxman Act: Proposed Legislative Changes Affecting Pharmaceutical Patents
No Description digital.library.unt.edu/ark:/67531/metacrs4055/
The Hatch-Waxman Act: Proposed Legislative Changes Affecting Pharmaceutical Patents
No Description digital.library.unt.edu/ark:/67531/metacrs4056/
The Hatch-Waxman Act: Proposed Legislative Changes Affecting Pharmaceutical Patents
No Description digital.library.unt.edu/ark:/67531/metacrs4057/
The Hatch-Waxman Act: Proposed Legislative Changes Affecting Pharmaceutical Patents
No Description digital.library.unt.edu/ark:/67531/metacrs4058/
The Hatch-Waxman Act: Proposed Legislative Changes Affecting Pharmaceutical Patents
No Description digital.library.unt.edu/ark:/67531/metacrs5774/
The Cost of Prescription Drugs for the Uninsured Elderly and Legislative Approaches
The purpose of this report is to explain why many of those who are least able to afford high drug costs are those who are most frequently charged the most. This report describes the basic economic theory underlying price differentiation and, in the context of the pharmaceutical market, analyzes the role and behavior of pharmacy benefit managers (PBMs), pharmaceutical manufacturers, and retail pharmacies, respectively. It also looks at a number of the criticisms that have been made of the practice of differential pricing. Finally, this report discusses various policy approaches aimed at assisting the elderly to purchase prescription drugs. digital.library.unt.edu/ark:/67531/metacrs1520/
President Bush's Proposed Medicare-Endorsed Drug Discount Card Initiative: Status and Issues
No Description digital.library.unt.edu/ark:/67531/metacrs2330/
President Bush's Proposed Medicare-Endorsed Drug Discount Card Initiative: Status and Issues
No Description digital.library.unt.edu/ark:/67531/metacrs2331/
FIRST PREV 1 2 3 4 5 NEXT LAST